Differential expression, regulation, and induction of Smads, transforming growth factor-β signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1350-1361

  Xu, Jingxia ^a   Luo, Xiaoping ^a   Chegini, Nasser ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GONADORELIN DERIVATIVE; SMAD PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; DOSE TIME EFFECT RELATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TUMOR GROWTH; TUMOR REGRESSION; WESTERN BLOTTING;

DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEIOMYOMA; LEUPROLIDE; MYOCYTES, SMOOTH MUSCLE; MYOMETRIUM; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037339118     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021325     Document Type: Article

References (54)

1. Kettel LM, Murphy AA, Morales AJ, Rivier J, Vale W, Yen SS 1993 Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist Fertil Steril 60:642-646
2. Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N 2000 A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynecol Res 26:325-331
3. Chegini N 2000 Implication of growth factor and cytokine networks in leiomyomas. In: Hill J, ed. Cytokines in human reproduction. New York: Wiley & Sons; 133-162.
4. Nowak RA 1999 Fibroids: pathophysiology and current medical treatment. Bailliere Best Pract Res Clin Obstet Gynaecol 13:223-238
5. Lawrence DA 1996 Transforming growth factor-β: a general review. Eur Cytokine Network 7:363-374
6. Branton MH, Kopp JB 1999 TGF-β and fibrosis. Microbes Infect 1:1349-1365
7. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, Chegini N 1996 Suppression of TGF-βs and TGF-β receptors mRNA and protein expression in leiomyomata in women receiving gonadotropin releasing hormone agonist therapy. J Clin Endocrinol Metab 81:3222-3230
8. Chegini N, Tang XM, Ma C 1999 Regulation of transforming growth factor-β1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 84:4138-4143
9. Lee BS, Nowak RA 2001 Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGF β3) and altered responses to the antiproliferative effects of TGF β. J Clin Endocrinol Metab 86:913-920
10. Arici A, Sozen I 2000 Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73:1006-1011
11. Chegini N, Tang XM, Ma C, Williams RS 2002 Effects of GnRH analogues, add-back, steroid therapy antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cells growth and transforming growth factor β expression. Mol Hum Reprod 8:1071-1078
12. Zimmerman CM, Padgett RW 2000 Transforming growth factor β signaling mediators and modulators. Gene 249:17-30
13. Massague J, Wotton D 2000 Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19:1745-1754
14. Moustakas A, Souchelnytskyi S, Heldin CH 2001 Smad regulation in TGF-β signal transduction. J Cell Sci 114:4359-4369
15. Kretzschmar M, Doody J, Timokhina I, Massagué J 1999 A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. Genes Dev 13:804-816
16. Lee S, Cho YS, Shim C, Kim J, Choi J, Oh S, Kim J, Zhang W, Lee J 2001 Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-β in the SiHa human cervical carcinoma cell line. Int J Cancer 94:500-507
17. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM 1999 Elevation of expression of Smads 2, 3, and 4, decorin and TGF-β in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667-678
18. Chegini N, Kornberg L 2003 Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving MAP and focal adhesion kinases in leiomyoma. J Soc Gynecol Invest 10:21-26
19. Rossi MJ, Chegini N, Masterson BJ 1992 Presence of EGF, PDGF and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology 130:1716-1727
20. Xu G, Chakraborty C, Lala PK 2001 Expression of TGF-β signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun 287:47-55
21. Ott TR, Troskie BE, Roeske RW, Illing N, Flanagan CA, Millar RP 2002 Two mutations in extracellular loop 2 of the human GnRH receptor convert an antagonist to an agonist. Mol Endocrinol 16:1079-1088
22. Grundker C, Gunthert AR, Millar RP, Emons G 2002 Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 87:1427-1430
23. Cheon KW, Lee HS, Parhar IS, Kang IS 2001 Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 7:447-452
24. 6 in the ligand and extracellular loop two of the receptor as determinants. J Biol Chem 276:7754-7761
25. Hislop JN, Everest HM, Flynn A, Hardlng T, Uney JB, Troskie BE, Millar RP, McArdle CA 2001 Differential internalization of mammalian and non-mammalian gonadotropin-releasing hormone receptors. Uncoupling of dynamin-dependent internalization from mitogen-activated protein kinase signaling. J Biol Chem 276:39685-39694
26. 125I-TGF-β1-binding sites. Endocrinology 135:439-449
27. Tang XM, Dou Q, Zhao Y, McLean F, Davis J, Chegini N 1997 The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro. Mol Hum Reprod 3:233-240
28. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, ten Dijke P, White B, Wigley FM, Goldschmidt-Clermont PJ 2002 Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 99:3908-3913
29. Mori Y, Chen SJ, Varga J 2000 Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β. Exp Cell Res 258:374-383
30. Pulaski L, Landstrom M, Heldin CH, Souchelnytskyi S 2001 Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J Biol Chem 276:14344-14349
31. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I 1999 Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5-11
32. Kato S, Ueda S, Tamaki K, Fujii M, Miyazono K, ten Dijke P, Morimatsu M, Okuda S 2001 Ectopic expression of Smad7 inhibits transforming growth factor-β responses in vascular smooth muscle cells. Life Sci 69:2641-2652
33. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP 2001 Apoptosis in podocytes induced by TGF-β and Smad7. J Clin Invest 108:807-816
34. Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, ten Dijke P, Heldin CH 2000 Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells. Curr Biol 10:535-538
35. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP 2000 A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 14:187-197
36. Afrakhte M, Moren A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin CH, Heldin NE, ten Dijke P 1998 Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249:505-511
37. Zhao Y, Geverd DA 2002 Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-β signaling. Biochem Biophys Res Commun 294:319-323
38. Zhao J, Shi W, Wang YL, Chen H, Bringas P Jr, Datto MB, Frederick JP, Wang XF, Warburton D 2002 Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol 282:L585-L593
39. Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J 2000 Interaction of smad3 with a proximal smad-binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF-β. J Cell Physiol 183:381-392
40. Yuan W, Varga J 2001 Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 276:38502-38510
41. Poncelet AC, Schnaper HW 2001 Sp1 and Smad proteins cooperate to mediate transforming growth factor-β 1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 276:6983-6992
42. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL 2000 Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF b receptor for degradation. Mol Cell 6:1365-1375
43. Mulder KM 2000 Role of Ras and MAPKs in TGF-β signaling. Cytokine Growth Factor Rev 11:23-35
44. Yue J, Mulder KM 2000 Requirement of Ras/MAPK pathway activation by transforming growth factor β for transforming growth factor β1 production in a Smad-dependent pathway. J Biol Chem 275:30765-30773
45. Yakymovych I, Ten Dijke P, Heldin CH, Souchelnytskyi S 2001 Regulation of Smad signaling by protein kinase C. FASEB J 15:553-555
46. Uchida K, Suzuki H, Ohashi T, Nitta K, Yumura W, Nihei H 2001 Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem Biophys Res Commun 289:376-381
47. Cheng KW, Leung PC 2000 The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor. Can J Physiol Pharmacol 78:1029-1052
48. Kraus S, Naor Z, Seger R 2001 Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res 32:499-509
49. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, Lechleider RJ 1998 Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12:1587-1592
50. Scherer A, Graff JM 2000 Calmodulin differentially modulates Smad1 and Smad2 signaling. J Biol Chem 275:41430-41438
51. Zimmerman CM, Kariapper MST, Mathews LS 1997 Smad proteins physically interact with calmodulin. J Biol Chem 273:677-680
52. Pouliot F, Labrie C 1999 Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. Int J Cancer 81:98-103
53. Xie W, Mertens JC, Reiss DJ, Rimm DL, Camp RL, Haffty BG, Reiss M 2002 Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res 62:497-505
54. Brodin G, ten Dijke P, Funa K, Heldin CH, Landstrom M 1999 Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59:2731-2738